Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Weijer, Ruud ^a   Broekgaarden, Mans ^a   van Golen, Rowan F ^a   Bulle, Esther ^a   Nieuwenhuis, Esther ^a   Jongejan, Aldo ^a   Moerland, Perry D ^a   van Kampen, Antoine H C ^a   van Gulik, Thomas M ^a   Heger, Michal ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Drug delivery system; Metallated phthalocyanines; Non resectable perihilar cholangiocarcinoma; Therapeutic recalcitrance; Tumor targeting

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ATROGIN 1; CATION TRANSPORT PROTEIN; COLONY STIMULATING FACTOR; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DUAL SPECIFICITY PHOSPHATASE 6; ENDOTHELIN 1; EPHRIN RECEPTOR A1; HEAT SHOCK PROTEIN; HYPOCALCIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHTHALOCYANINE ZINC; PROTEIN BCL 2; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL NUCLEOLAR RNA; STROMELYSIN 2; THROMBOSPONDIN; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR SOX; UBIQUITIN; VASCULOTROPIN A; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; ZN(II)-PHTHALOCYANINE;

ANIMAL CELL; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CELL DEATH; CELL HYPOXIA; CELL VIABILITY; CHICKEN; CHOLANGIOCARCINOMA CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; EMBRYO; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; SIGNAL TRANSDUCTION; TOXICITY TESTING; TOXICOGENETICS; TOXICOLOGY; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; BILE DUCT NEOPLASMS; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KLATSKIN TUMOR; MALE; METABOLISM; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY;

ANIMALS; BILE DUCT NEOPLASMS; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDOLES; KLATSKIN TUMOR; LIPOSOMES; MALE; MICE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84951739787     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1994-2     Document Type: Article

References (53)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: An update. CA Cancer J Clin. 2011;61(4):250-81.
2. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6(7):535-45.
3. Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist. 2006;11(9):1034-44.
4. Copper MP, Tan IB, Oppelaar H, Ruevekamp MC, Stewart FA. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129(7):709-11.
5. Mackenzie GD, Dunn JM, Selvasekar CR, Mosse CA, Thorpe SM, Novelli MR, et al. Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. Lasers Med Sci. 2009;24(5):729-34.
6. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology. 1995;108(2):337-44.
7. Zeitouni NC, Shieh S, Oseroff AR. Laser and photodynamic therapy in the management of cutaneous malignancies. Clin Dermatol. 2001;19(3):328-38.
8. Sun ZQ. Photodynamic therapy of nasopharyngeal carcinoma by argon or dye laser- an analysis of 137 cases. Zhonghua Zhong Liu Za Zhi. 1992;14(4):290-2.
9. Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G, et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2003;57(7):860-7.
10. Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Tumor cell survival pathways activated by photodynamic therapy: a molecular framework for inhibition strategies. Cancer Metastasis Rev. 2015;34(4):643-90.
11. Weijer R, Broekgaarden M, Kos M, van Vught R, Rauws EA, Breukink E, et al. Enhancing photodynamic therapy of refractory solid cancers: combining second-generation photosensitizers with multi-targeted liposomal delivery. J Photochem Photobiol C: Photochem Rev. 2015;23:103-31.
12. Lee TL, Chan WY, Rennert OM. Assessing the safety of nanomaterials by genomic approach could be another alternative. ACS Nano. 2009;3(12):3830.
13. Luna MC, Wong S, Gomer CJ. Photodynamic therapy mediated induction of early response genes. Cancer Res. 1994;54(5):1374-80.
14. Broekgaarden M, de Kroon AIPM, van Gulik TM, Heger M. Development and in vitro proof-of-concept of interstitially targeted zinc-phthalocyanine liposomes for photodynamic therapy. Curr Med Chem. 2014;21(3):377-91.
15. Valdes TI, Kreutzer D, Moussy F. The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J Biomed Mater Res. 2002;62(2):273-82.
16. Watanabe H. Toxicogenomics as a tool for evaluation of chemical effects. Yakugaku Zasshi. 2007;127(12):1967-74.
17. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17(9):2596-606.
18. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76-86.
19. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313-22.
20. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 1998;17(24):3145-56.
21. Dufey E, Sepulveda D, Rojas-Rivera D, Hetz C. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 1. An overview. Am J Physiol Cell Physiol. 2014;307(7):C582-94.
22. Kim R, Emi M, Tanabe K, Murakami S. Role of the unfolded protein response in cell death. Apoptosis. 2006;11(1):5-13.
23. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, et al. Prolyl hydroxylase-1 negatively regulates I kappa B kinase-beta, giving insight into hypoxia-induced NF kappa B activity. Proc Natl Acad Sci U S A. 2006;103(48):18154-9.
24. Aggarwal BB. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol. 2003;3(9):745-56.
25. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5(5):343-54.
26. Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36(9):2179-86.
27. Lee TY, Cheon YK, Shim CS. Current status of photodynamic therapy for bile duct cancer. Clin Endosc. 2013;46(1):38-44.
28. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127-52.
29. Frank J, Lambert C, Biesalski HK, Thews O, Vaupel P, Kelleher DK. Intensified oxidative and nitrosative stress following combined ALA-based photodynamic therapy and local hyperthermia in rat tumors. Int J Cancer. 2003;107(6):941-8.
30. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 1997;275(5296):90-4.
31. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 2001;15(7):1312-4.
32. Liu KH, Wang CP, Chang MF, Chung YW, Lou PJ, Lin JH. Molecular characterization of photosensitizer-mediated photodynamic therapy by gene expression profiling. Hum Exp Toxicol. 2013;33(6):629-37.
33. Kammerer R, Buchner A, Palluch P, Pongratz T, Oboukhovskij K, Beyer W, et al. Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy. PLoS One. 2011;6(6):e21834.
34. Liu GH, Qu J, Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta. 2008;1783(5):713-27.
35. Fabris C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S, et al. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res. 2001;61(20):7495-500.
36. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, et al. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett. 2006;244(2):182-9.
37. Chen W-H, Lecaros RLG, Tseng Y-C, Huang L, Hsu Y-C. Nanoparticle delivery of HIF1aα siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. Cancer Lett. 2015;359(1):65-74.
38. Kim CH, Chung CW, Lee HM, Kim do H, Kwak TW, Jeong YI, et al. Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells. Int J Nanomedicine. 2013;8:2173-86.
39. Vosooghi M, Amini M. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies. Expert Opin Drug Discov. 2014;9(3):255-67.
40. Lee K, Zhang H, Qian DZ, Rey S, Liu JO, Semenza GL. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci U S A. 2009;106(42):17910-5.
41. Weijer R, Broekgaarden M, Krekorian M, Alles LK, van Wijk AC, Mackaaij C, et al. Inhibition of hypoxia inducible factor 1 with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. Oncotarget. in press.
42. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y, Fulda S, et al. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. Biochem Pharmacol. 2011;81(5):606-16.
43. Edmonds C, Hagan S, Gallagher-Colombo SM, Busch TM, Cengel KA. Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer. Cancer Biol Ther. 2012;13(14):1463-70.
44. Pawlus MR, Wang L, Hu CJ. STAT3 and HIF1alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 2014;33(13):1670-9.
45. Fan Y, Mao R, Yang J. NF-ΚB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4(3):176-85.
46. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112-6.
47. Kind C. The development of the circulating blood volume of the chick embryo. Anat Embryol. 1975;147(2):127-32.
48. Riches AC, Sharp JG, Thomas DB, Smith SV. Blood volume determination in the mouse. J Physiol. 1973;228(2):279-84.
49. Vacha J. Blood volume in inbred strain BALB/c, CBA/J and C57BL/10 mice determined by means of 59Fe-labelled red cells and 59Fe bound to transferrin. Physiol Bohemoslov. 1975;24(5):413-9.
50. van Golen RF, Reiniers MJ, Verheij J, Heger M. Solutions to the discrepancies in liver damage profiles following ischemia/reperfusion in standardized mouse models. J Hepatol. 2015;62(4):975-7.
51. Wu D, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics. 2010;26(17):2176-82.
52. Kutmon M, van Iersel MP, Bohler A, Kelder T, Nunes N, Pico AR, et al. PathVisio 3: An extendable pathway analysis toolbox. PLoS Comput Biol. 2015;11(2):e1004085.
53. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37(6):e45.